Please check the individual session for location or broadcast availability.
Jay-Jiguang Zhu, MD, PhD
Target Audience and Needs
Pathologists, radiologists, researchers and other healthcare providers need to be regularly updated on advances in the diagnosis and treatment of central nervous system tumors. The tumor board aims to increase knowledge of the learners in these topic areas, and encourages learners to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.
Educational methods will include case presentations and panel discussions.
At the conclusion of the sessions, the participants should be able to:
- Deliver effective healthcare and stay current on advances in diagnosis and treatment approaches for central nervous system (CNS) tumors, as well as research findings.
- Discuss the benefits and limitations of the current medical and surgical treatment strategies for CNS tumors.
- Analyze and interpret the pathology of CNS tumors, the results of radiographic imaging, and other data that are essential to each case.
Participants may be asked to complete a session evaluation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Baylor College of Medicine and The University of Texas Health Science Center at Houston. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.